Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-29

FDA Approved: FULVESTRANT — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

The FDA approved a generic fulvestrant product from Zydus Lifesciences Limited under an Original Application for the treatment of estrogen receptor-positive met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fulvestrant (fulvestrant)

Snippet

ORIG AP for FULVESTRANT (FULVESTRANT)